tirzepatide research peptide 20mg UK Tirzepatide Research Peptide | cGMP

Di Mauro A, Tuccinardi D, Watanabe M, Del Toro R, Monte L, Giorgino R, et al

Gastroparesis and severe GI motility problems on tirzepatide In December 2025, the FDA updated both the Mounjaro and Zepbound prescribing information to add a specific warning about severe gastroparesis (Section 5.6): tirzepatide is not recommended for people with pre-existing severe gastroparesis

This practice does not sell medications

The injectable route ensures consistent B6 delivery regardless of how your gut is functioning on any given day

While tirzepatide is effective for many people, questions have come up about possible side effects, including back pain